Overview

A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

According to the results of the phase II study, choose the best dose of JINTOPIN AQ for short SGA children, further to evaluate the efficacy and safety of the treatment of short SGA children.

Phase:

Phase 3

Details

Lead Sponsor:

GeneScience Pharmaceuticals Co., Ltd.

Collaborators:

Beijing Children's Hospital
Shanghai Children's Hospital
The Children's Hospital of Zhejiang University School of Medicine
The First Affiliated Hospital with Nanjing Medical University
Tongji Hospital

Treatments:

Hormones